Skip to main content
Equibles
CDIO logo

CDIO · Cardio Diagnostics Holdings, Inc. · Metrics

Track CDIO — free

Use CDIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CDIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.77 +0.05 (+2.91%) At close · Oct 21
Rebalance outlook locked
Market Cap
$5.24M
Shares
2.96M
Volume · Oct 21 29.26K Avg daily vol (3M) 56.91K

CDIO metrics

76 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.77
Market cap
$5.24M

Price action

20 metrics
Price change (1W)
+6.0%
Price change (30D)
-7.8%
Price change (3M)
+5.4%
Price change (6M)
-7.3%
Price change (YTD)
-34.7%
Price change (1Y)
-59.3%
Trailing year
Price change (5Y)
—
52-week high
$6.55
52-week low
$1.05
Change from 52-week high
-73.0%
Change from 52-week low
+68.6%
Annualized volatility
148.6%
Annualized volatility (3M)
71.1%
Beta
3.1
RSI (14D)
45.3
Price vs SMA 50
-7.7%
Price vs SMA 200
-15.2%
Avg volume (3M)
56,912
Relative volume
0.5
Average dollar volume
$102,157

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
2.96M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
362.5×
reciprocal yield 0.3%
P / book
0.7
reciprocal yield 141.8%
FCF yield
-111.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-123.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-44,690.7%
Trailing 12 months
Net margin
-44,771.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$6.46M
Net income (TTM)
−$6.47M
Trailing 12 months
Diluted EPS (TTM)
$-2.91
FCF margin
-40,307.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.01
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-2.91
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-2.92
Operating cash flow per diluted share (TTM)
$-2.54
Free cash flow per diluted share (TTM)
$-2.64
Capital expenditures per diluted share (TTM)
$0.09
R&D per diluted share (TTM)
$0.29
Stock compensation per diluted share (TTM)
$0.04
Book value per share
$3.82

Growth

11 metrics
Revenue growth YoY
-28.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$14,450
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+70.2%
Year over year · more shares
Revenue CAGR (3Y)
+149.9%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-87.1%
Return on assets
-81.6%
Debt / equity
—
Current ratio
17.1
EBITDA (TTM)
−$6.44M
Free cash flow (TTM)
−$5.82M
Quick ratio
17.1
Interest coverage
-525.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$0
Latest balance sheet
Cash & equivalents
$0
Total assets
$7.93M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.66M
Capital expenditures (TTM)
$164,594
R&D (TTM)
$636,597
SG&A (TTM)
—
Stock compensation (TTM)
$97,930
R&D / revenue
4,405.5%
Stock compensation / revenue
677.7%

Ownership (13F)

9 metrics
13F filers
23
13F filer change QoQ
+1
Institutional ownership
24.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
3.3%
Private-fund adviser ownership
2.3%
Active holders' share change QoQ
-46.6%
Holder tenure
4.6
Price vs estimated holder cost
-78.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.4%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
21 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1870144 CUSIP 14159C202 13F (30d) 1 filings 1 filers Visit website Investor relations